Junyan Zhang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Junyan zhang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Junyan Zhang Today - Breaking & Trending Today

ORNL: Novel composite catalyst holds promise for cost-effective ethanol-to-jet-fuel conversion


Share
Decarbonizing air transportation is critical to meeting U.S. climate goals and improving the nation’s energy economy. But technologies that are transforming automobiles – such as electric motors and hydrogen fuels – are difficult to implement in aircraft.
A battery powerful enough to fuel an airplane would be prohibitively heavy. Hydrogen is only one quarter as energy dense as jet fuel (and many times more expensive) but would require large complex storage tanks onboard. To greatly reduce its emissions, the U.S. commercial aviation sector will need new methods of making sustainable aviation fuel.
The well-established, cost-competitive ethanol market provides an opportunity to shift the composition of jet fuel and other fuel products away from petroleum. The Department of Energy’s Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office is focused on developing industrially viable fuels using renewable biomass, including national labo ....

Junyan Zhang , Jeremy Kropf , Zhenglong Li , Rajeev Assary , Theodore Krause , Lawrence Allard , Stephen Purdy , Dongxia Liu , Huamin Wang , Kinga Unocic , Jeffrey Miller , Mingxia Zhou , Purdue University , University Of Maryland , Pacific Northwest National Laboratory , Renewable Energy Bioenergy Technologies Office , Oak Ridge National Laboratory , Argonne National Laboratory , Department Of Energy Office Efficiency , Energy Efficiency , Ridge National Laboratory , Even Wegener , Fan Lin , ஜெர்மி க்ரோபப் , ஸ்டீபன் ஊதா , ஜெஃப்ரி மில்லர் ,

Researchers Identify Potential Targets for Novel Treatments for Lung Cancer


Date Time
Researchers Identify Potential Targets for Novel Treatments for Lung Cancer
Lung cancer is the most common cause of cancer deaths, accounting for about a third of all tumor-related deaths. Adenocarcinomas, a non-small cell lung cancer (NSCLC), account for about 40 percent of cancer diagnoses, but few treatments are available for the disease.
A team of investigators led by Elena Levantini, PhD, a research associate in Hematology-Oncology in the laboratory of Daniel Tenen MD, at Beth Israel Deaconess Medical Center (BIDMC), evaluated a novel agent, PTC596, capable of decreasing tumor growth in preclinical studies performed on a mouse model of mutant K-RAS lung cancer. The research – performed in collaboration with the Cancer Science Institute of Singapore at the National University of Singapore (CSI NUS) – were published today in the journal Communications Biology. The findings, which represent a comprehensive snapshot of the tumor’s components, will faci ....

United States , National University Of Singapore , Singapore General , Junyan Zhang , Henry Yang , John Clohessy , Mahmoud Bassal , Jia Li , Azhar Ali , Eva Csizmadia , Nicole Pandell , Indira Krishnan , Raphael Bueno , Giorgia Maroni , Allon Klein , Danielg Tenen , Regione Toscana Bando , Riccardo Panella , Elena Levantini , Olivier Kocher , Valerie Myami , National Cancer Institute , Beth Israel Deaconess Medical Center , University Of Alabama At Birmingham , American Society Of Hematology , Cancer Science Institute Of Singapore ,